[go: up one dir, main page]

DE3875871D1 - Antiinfektioese verbindungen und verfahren zur verwendung. - Google Patents

Antiinfektioese verbindungen und verfahren zur verwendung.

Info

Publication number
DE3875871D1
DE3875871D1 DE8888902681T DE3875871T DE3875871D1 DE 3875871 D1 DE3875871 D1 DE 3875871D1 DE 8888902681 T DE8888902681 T DE 8888902681T DE 3875871 T DE3875871 T DE 3875871T DE 3875871 D1 DE3875871 D1 DE 3875871D1
Authority
DE
Germany
Prior art keywords
c2h4o
compound
present
treating
hltv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888902681T
Other languages
English (en)
Other versions
DE3875871T2 (de
Inventor
L Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of DE3875871D1 publication Critical patent/DE3875871D1/de
Application granted granted Critical
Publication of DE3875871T2 publication Critical patent/DE3875871T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8888902681T 1987-02-20 1988-02-19 Antiinfektioese verbindungen und verfahren zur verwendung. Expired - Fee Related DE3875871T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1733087A 1987-02-20 1987-02-20
US15073188A 1988-02-16 1988-02-16
PCT/US1988/000510 WO1988006038A1 (en) 1987-02-20 1988-02-19 Antiinfective compounds and method of use

Publications (2)

Publication Number Publication Date
DE3875871D1 true DE3875871D1 (de) 1992-12-17
DE3875871T2 DE3875871T2 (de) 1993-04-01

Family

ID=26689732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888902681T Expired - Fee Related DE3875871T2 (de) 1987-02-20 1988-02-19 Antiinfektioese verbindungen und verfahren zur verwendung.

Country Status (9)

Country Link
EP (1) EP0305470B1 (de)
JP (1) JPH01503458A (de)
AT (1) ATE82129T1 (de)
AU (1) AU1396588A (de)
CA (1) CA1314221C (de)
DE (1) DE3875871T2 (de)
DK (1) DK582588A (de)
FI (1) FI884850A (de)
WO (1) WO1988006038A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
DE69230372T2 (de) 1991-03-19 2000-06-15 Cytrx Corp., Norcross Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
EP0682524B1 (de) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5932544A (en) * 1994-05-31 1999-08-03 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
DE10358534A1 (de) 2003-12-13 2005-07-14 Henkel Kgaa Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
JPS5283936A (en) * 1976-01-01 1977-07-13 Ortho Pharma Corp Single herpes virus inactivating acent
DE2732929A1 (de) * 1977-07-21 1979-02-01 Bayer Ag Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
JPS5449322A (en) * 1977-09-26 1979-04-18 Daicel Chem Ind Ltd Non-medical anti-bacterial and anti-mold agent
JPS5668616A (en) * 1979-11-08 1981-06-09 Yukio Kimura Preparation of antibiotic composition
JPS579717A (en) * 1980-06-20 1982-01-19 Nippon Shinyaku Co Ltd Germicidal composition
US4376118A (en) * 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung

Also Published As

Publication number Publication date
EP0305470A1 (de) 1989-03-08
DK582588A (da) 1988-12-12
ATE82129T1 (de) 1992-11-15
FI884850A0 (fi) 1988-10-20
JPH01503458A (ja) 1989-11-22
DK582588D0 (da) 1988-10-19
DE3875871T2 (de) 1993-04-01
FI884850A (fi) 1988-10-20
CA1314221C (en) 1993-03-09
WO1988006038A1 (en) 1988-08-25
AU1396588A (en) 1988-09-14
EP0305470B1 (de) 1992-11-11

Similar Documents

Publication Publication Date Title
DE3875871D1 (de) Antiinfektioese verbindungen und verfahren zur verwendung.
Emmons et al. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case
Gagliardi et al. Microbial flora of the normal esophagus
Giamarellou et al. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa
CA2006953A1 (en) Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
UA42699C2 (uk) Бензоксазинонові сполуки, спосіб інгібування зворотної транскриптази, попередження або лікування, комбінації та фармацевтичні композиції
Adler et al. Development of an improved selective medium for isolation of leptospires from clinical material
HUT60713A (en) Process for producing pharmaceutical compositions suitable for treating hiv infections and for producing their active ingredients
Chirino-Trejo et al. Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis
Holmberg et al. Antimicrobial in vitro susceptibility of Actinomyces israelii and Arachnia propionica
Vanhoof et al. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms
Holton et al. Mycobacterium haemophilum infection in a patient with AIDS
Lai A cancer patient with central venous catheter-related sepsis caused by Tsukamurella paurometabolum (Gordona aurantiaca)
Goetz et al. Effects of some antibiotics on the growth of human diploid skin fibroblasts in cell culture
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
Muhammad et al. Interspecific conjugal transfer of antibiotic resistance among staphylococci isolated from the bovine mammary gland
Callapina et al. Systemic and intracerebral infections of mice with Listeria monocytogenes successfully treated with linezolid
Berger et al. Penetration of clindamycin into decubitus ulcers
Kato et al. Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria
Swerczek Inhibition of the CEM organism by the normal flora of the reproductive tract
Bisgaard et al. Isolation of Pasteurella caballi from an infected wound on a veterinary surgeon
Duran et al. In-vitro antimicrobial susceptibility of Bacteroides and Fusobacterium isolated from footrot in goats
DE69119488D1 (de) Disulfat von WS-7622A, Verfahren zur Herstellung und Benutzung
Skeeles et al. Studies on the use of a long-acting oxytetracycline in turkeys: Efficacy against experimental infections with Alcaligenes faecalis and Pasteurella multocida
Donnelly et al. Susceptibility of laboratory rats, hamsters, and mice to wound infection with Staphylococcus aureus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee